Orthofix to Participate in Upcoming Investor Conferences

About this update from Orthofix Medical Inc.

LEWISVILLE, Texas --(BUSINESS WIRE)-- Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore , President and Chief Executive Officer, and Julie Andrews , Chief Financial Officer, will participate in the following investor conferences: UBS Global Healthcare Conference in Palm Beach Gardens, FL , November 11, 2025 , at 1:15 pm Eastern Time Stifel Healthcare Conference in New York, NY , November 12, 2025 , at 10:00 am Eastern Time Jefferies Global Healthcare Conference in London, UK , November 18-19, 2025 , 1x1 meetings only Interested parties can access the live and archived webcast of the presentations in the “Events & Presentations” section of the Orthofix Investor Relations Website at ir.orthofix.com . Internet Posting of Information Orthofix regularly shares important updates in the “Investors” section of its website at www.orthofix.com . The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix . About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas . By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ Navigation System. To learn more, visit Orthofix.com and follow on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20251015092881/en/ Company Contact: I nvestors and Media Julie Dewey , IRC Chief Investor Relations & Communications Officer [email protected] 209.613.6945 Source: Orthofix Medical Inc.

View stock analysis, news, and events for Orthofix Medical Inc.